Ryan Bransfield, dividend analyst at Markit, says emerging market companies are maturing and paying out more dividends.» Read More
The latest surge in Apple's stock is not due to speculation about its next revolutionary product, but rather the possibility of a dividend, or even a share split, traders said.
Discussing whether now is the time to start taking more market risks, or whether safer investments like dividends are still the better way to go, with Bill McVail, Turner Small Cap Growth Fund and Michael Cuggino, Permanent Portfolio Funds
Stephen Holmes, Wyndham Worldwide chairman &CEO, discusses his company's 53% dividend boost, and its turnaround story, with Mad Money's, Jim Cramer.
Thomas Farrell, Dominion Resources CEO, discusses his company's solid quarter and the outlook for natural gas, with Mad Money's Jim Cramer.
Tuesday’s market action provided a glimpse into what the market wants and want it doesn’t want, the “Mad Money” told viewers.
Consumer advocate, Ralph Nader, explains why he wants Cisco to boost its dividend, and explains his "penny" campaign, with the Fast Money traders.
Cramer thinks big pharma stocks could soon pop, so here's his preferred plays.
Mad Money's Cramer, explains why Sanofi-Aventis is his favorite medical breakthrough stock, saying it has excellent management; its growth platforms are working; and it supplies a juicy dividend.
First Niagara Bank is up 2% today - The northeastern bank posted record earnings results for 2011. John Koelmel, First Niagara Bank president & CEO, discusses.
The S&P tech sector hit a new intraday high today- the highest intraday level in more than 10 years. Tara Hedlund, Turner Investments, weighs in on the Apple phenomenon. "Our expectation is that Apple will initiate a dividend this year," she says.
If investors are looking for a big pharma play that hasn't already run up, then go bottom feeding with Johnson & Johnson, says Mad Money's Jim Cramer. It's not the best company in the business, but there are many positives in its future.
Rich Kinder spoke with Cramer on Tuesday’s “Mad Money.”
Why the “Mad Money” host is bullish on both pharmaceutical stocks.
Mad Money's Cramer says dividends are the best source of wealth that stocks can give investors, and there is no better way to find out about the prospects for increased dividends than to listen to the earnings calls.
Historically, dividend payments have accounted for more than 40 percent of the S&P 500’s total returns. Here are the top companies with 15 years or more of consecutive dividend increases.
The UK’s fraud investigator intends to confiscate shareholder dividends paid by companies convicted of criminal offences, after it won approval for a landmark court action, the Financial Times reports.
Mad Money's Jim Cramer explains why he thinks, hydraulic fracturing company, Key Energy presents a fabulous buying opportunity for investors.
Insight on whether dividend stocks can outperform in weakness and in strength, with Brian Belski, Oppenheimer & Co. and Victor Sperandeo, Alpha Financial Technologies.
Discussing the outllook for JC Penney and whether the stock has already seen its highs for the year, with Jan Kniffen, J. Rogers Kniffen CEO.
CNBC's Herb Greenberg delivers a dividend quality check on Mattel, Unilever, and Altria.